Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.
Caitlin McCarthy, PharmD, BCPP
Advertisement
Articles by Caitlin McCarthy, PharmD, BCPP
Advertisement
Latest Updated Articles
Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary UpdatePublished: August 21st 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
5
